Stacey Pisklak, MD
Psychiatry · Bellaire, TXNPI 1518257385
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,385 of the $4,585 with a category attached, or 73.8%. 21 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 28.9% of the total. Reporting peaked in 2024 at $1,468 and has fallen 90.4% since, to $141 in 2025.
Across 166 payments — averaging $27.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$1K
- Lundbeck LLC$454
- Otsuka America Pharmaceutical, Inc.$450
- Johnson & Johnson$382
- Sunovion Pharmaceuticals Inc.$338
- Teva Pharmaceuticals USA, Inc.$288
- plus $1K from 15 others
What the payments were for
- Consulting fees$1,20026%
- Food & beverage$3,38574%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $1,325 |
| Lundbeck LLC | 37 | $454 |
| Otsuka America Pharmaceutical, Inc. | 28 | $450 |
| Johnson & Johnson | 16 | $382 |
| Sunovion Pharmaceuticals Inc. | 21 | $338 |
| Teva Pharmaceuticals USA, Inc. | 6 | $288 |
| Neurocrine Biosciences, Inc. | 11 | $225 |
| AbbVie(2 entities) | 12 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $151 |
| Apellis Pharmaceuticals, Inc. | 1 | $141 |
| Shire North American Group Inc | 9 | $134 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Corium, LLC | 1 | $112 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| Eisai Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Adlon Therapeutics L.p. | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| OWP Pharmaceuticals, Inc. | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,585 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate ErQuetiapine Fumarate | 25 | $1,568 |
| Quetiapine Fumarate | 37 | $1,097 |
| Sertraline Hcl | 45 | $702 |
| Duloxetine Hcl | 12 | $662 |
| Bupropion XlBupropion Hcl | 19 | $627 |
| Clonazepam | 49 | $542 |
| Trazodone Hcl | 25 | $363 |
| Lamotrigine | 24 | $334 |
| Escitalopram Oxalate | 15 | $284 |
| Lithium Carbonate ErLithium Carbonate | 12 | $236 |
| Lorazepam | 28 | $218 |
| Alprazolam | 20 | $125 |
| Temazepam | 12 | $74 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Bellaire
- Donald HauserBellaire$108K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
- Frank ChenHouston$941K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.